Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis
31 Juillet 2023 - 2:30PM
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal
solutions company, today announced the commercial
launch of the MARVEL™ Growing Rod System, which is designed for
pediatric patients with early onset scoliosis to obtain and
maintain correction while allowing for growth through minimally
invasive distraction.
MARVEL™ growing rods feature a powerful geared
mechanism that provides reliable, efficient lengthening through a
large 40mm or 60mm expansion range, with PEEK polymer bearing
surfaces to minimize wear. Lengthening of each rod is achieved
through a minimally invasive procedure with a small incision for
driver access to minimize soft tissue disruption.
“The need to balance curve correction with growth
in patients with early onset scoliosis makes it one of the most
challenging conditions facing pediatric spine surgeons,” says Dr.
Shyam Kishan, board-certified orthopedic surgeon and Medical
Director at Medical City Children’s Hospital Orthopedics &
Spine in Dallas, TX. “MARVEL™’s novel design allows for reliable
distraction for continued spinal growth while minimizing impact to
the patient.”
“Globus Medical is committed to providing world
class solutions for the most complex spinal disorders,” said David
Hole, President, Spine at Globus Medical. “MARVEL™, together with
our recent launch of the REFLECT™ Scoliosis Correction System, a
non-fusion growth modulation system for treatment of skeletally
immature idiopathic scoliosis patients, demonstrates our commitment
to leveraging our product development engine to serve children with
scoliosis and the surgeons who care for them. We are very excited
to bring these innovations to the marketplace.”
To learn more,
visit GlobusMedical.com/products/MARVEL.
IndicationsMARVEL™ Growing Rods
are indicated in patients under 10 years of age with potential for
additional spine growth who require surgical treatment to obtain
and maintain correction of severe, progressive, life threatening,
early onset spinal deformities associated with thoracic
insufficiency, including early onset scoliosis, as part of a
growing rod construct.
About Globus Medical,
Inc. Globus Medical, Inc. is a leading
musculoskeletal solutions company based in Audubon, PA. The company
was founded in 2003 by an experienced team of professionals with a
shared vision to create products that enable surgeons to promote
healing in patients with musculoskeletal disorders. Additional
information can be accessed
at http://www.globusmedical.com.
Safe Harbor Statements All
statements included in this press release other than statements of
historical fact are forward-looking statements and may be
identified by their use of words such as “believe,” “may,” “might,”
“could,” “will,” “aim,” “estimate,” “continue,” “anticipate,”
“intend,” “expect,” “plan” and other similar terms. These
forward-looking statements are based on our current assumptions,
expectations and estimates of future events and trends.
Forward-looking statements are only predictions and are subject to
many risks, uncertainties and other factors that may affect our
businesses and operations and could cause actual results to differ
materially from those predicted. These risks and uncertainties
include, but are not limited to, health epidemics, pandemics
and similar outbreaks, including the COVID-19
pandemic, factors affecting our quarterly results, our ability
to manage our growth, our ability to sustain
our profitability, demand for our products, our ability to
compete successfully (including without limitation our ability to
convince surgeons to use our products and our ability to attract
and retain sales and other personnel), our ability to rapidly
develop and introduce new products, our ability to develop and
execute on successful business strategies, our ability to comply
with laws and regulations that are or may
become applicable to our businesses, our ability to safeguard
our intellectual property, our success in defending legal
proceedings brought against us, trends in the medical device
industry, general economic conditions, and other risks. For a
discussion of these and other risks, uncertainties and other
factors that could affect our results, you should refer to the
disclosure contained in our most recent annual report on Form 10-K
filed with the Securities and Exchange Commission, including the
sections labeled “Risk Factors” and “Cautionary Note Concerning
Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and
other filings with the Securities and Exchange Commission. These
documents are available at www.sec.gov. Moreover, we operate
in an evolving environment. New risk factors and uncertainties
emerge from time to time and it is not possible for us to predict
all risk factors and uncertainties, nor can we assess the impact of
all factors on our business or the extent to which any
factor, or combination of factors, may cause actual results to
differ materially from those contained in any forward-looking
statements. Given these risks and uncertainties, readers are
cautioned not to place undue reliance on any forward-looking
statements. Forward-looking statements contained in this press
release speak only as of the date of this press release. We
undertake no obligation to update any forward-looking statements as
a result of new information, events or circumstances or other
factors arising or coming to our attention after the date
hereof.
Contact: Brian
Kearns Senior Vice President, Business Development and
Investor RelationsPhone: (610)
930-1800 Email: investors@globusmedical.com www.globusmedical.com
Globus Medical (NYSE:GMED)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Globus Medical (NYSE:GMED)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024